Subtopic Deep Dive

GDNF-Mediated Axon Regeneration
Research Guide

What is GDNF-Mediated Axon Regeneration?

GDNF-mediated axon regeneration refers to the process where glial cell line-derived neurotrophic factor (GDNF) promotes peripheral nerve repair through RET/NCAM receptor signaling, Schwann cell secretion, and enhanced growth cone advancement.

GDNF targets a distinct subgroup of small dorsal root ganglion (DRG) neurons expressing GDNF receptor components, providing neuroprotection after nerve injury (Bennett et al., 1998, 617 citations). Exogenous GDNF administration mimics target organ reinnervation effects, accelerating axon outgrowth (Terenghi, 1999, 688 citations). Over 10 papers from the provided list address neurotrophic factors in peripheral nerve contexts, with foundational works exceeding 600 citations each.

15
Curated Papers
3
Key Challenges

Why It Matters

GDNF therapies enhance sensory-motor recovery post-traumatic nerve injury by protecting non-neurotrophin-responsive DRG neurons, as shown in rat spinal nerve injury models (Bennett et al., 1998). Schwann cells secrete GDNF to support regeneration, integrating with scaffolds and electrical stimulation for tissue-engineered nerve conduits (Ghasemi-Mobarakeh et al., 2011). Clinical translation faces hurdles like incomplete functional restoration, where less than half of repaired nerves regain excellent motor function (Grinsell and Keating, 2014). Terenghi (1999) demonstrated GDNF's role in mimicking target reinnervation, informing gene therapy and scaffold delivery strategies for peripheral neuropathies.

Key Research Challenges

Incomplete Functional Recovery

Peripheral nerve regeneration remains slow and incomplete, with less than half of patients regaining good motor or sensory function after repair (Grinsell and Keating, 2014). Current surgical techniques limit outcomes despite neurotrophic support (Fu and Gordon, 1997). GDNF delivery must overcome diffusion barriers in injury gaps.

Targeting Specific Neuron Subgroups

One-third of sensory neurons lack neurotrophin receptors, requiring GDNF for small DRG cells expressing RET/NCAM (Bennett et al., 1998). Selective protection demands precise receptor profiling post-injury. Variable GDNF responsiveness complicates broad application (Terenghi, 1999).

Translating to Clinical Therapies

Exogenous GDNF mimics target effects but faces delivery challenges in scaffolds and gene therapy (Ghasemi-Mobarakeh et al., 2011). Stem cell integration with GDNF shows preclinical promise but lacks human trials (Lindvall and Kokaia, 2010). Regulatory and scalability issues persist.

Essential Papers

1.

Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain

Magdalena Miranda, Juan Facundo Morici, María Belén Zanoni et al. · 2019 · Frontiers in Cellular Neuroscience · 1.3K citations

Brain Derived Neurotrophic Factor (BDNF) is a key molecule involved in plastic changes related to learning and memory. The expression of BDNF is highly regulated, and can lead to great variability ...

2.

The cellular and molecular basis of peripheral nerve regeneration

Susan Y. Fu, T. Gordon · 1997 · Molecular Neurobiology · 1.2K citations

3.

Peripheral Nerve Reconstruction after Injury: A Review of Clinical and Experimental Therapies

Damien Grinsell, Cameron Keating · 2014 · BioMed Research International · 1.0K citations

Unlike other tissues in the body, peripheral nerve regeneration is slow and usually incomplete. Less than half of patients who undergo nerve repair after injury regain good to excellent motor or se...

4.

Schwann Cells: Development and Role in Nerve Repair

Kristján R. Jessen, Rhona Mirsky, Alison C. Lloyd · 2015 · Cold Spring Harbor Perspectives in Biology · 717 citations

Schwann cells develop from the neural crest in a well-defined sequence of events. This involves the formation of the Schwann cell precursor and immature Schwann cells, followed by the generation of...

5.

Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation

Bruno Lima Giacobbo, Janine Doorduin, Hans Klein et al. · 2018 · Molecular Neurobiology · 699 citations

Brain-derived neurotrophic factor (BDNF) is one of the most studied neurotrophins in the healthy and diseased brain. As a result, there is a large body of evidence that associates BDNF with neurona...

6.

Application of conductive polymers, scaffolds and electrical stimulation for nerve tissue engineering

Laleh Ghasemi‐Mobarakeh, Molamma P. Prabhakaran, Mohammad Morshed et al. · 2011 · Journal of Tissue Engineering and Regenerative Medicine · 692 citations

Among the numerous attempts to integrate tissue engineering concepts into strategies to repair nearly all parts of the body, neuronal repair stands out. This is partially due to the complexity of t...

7.

Peripheral nerve regeneration and neurotrophic factors

Giorgio Terenghi · 1999 · Journal of Anatomy · 688 citations

The role of neurotrophic factors in the maintenance and survival of peripheral neuronal cells has been the subject of numerous studies. Administration of exogenous neurotrophic factors after nerve ...

Reading Guide

Foundational Papers

Start with Fu and Gordon (1997, 1197 citations) for cellular mechanisms, then Bennett et al. (1998, 617 citations) for GDNF-specific DRG targeting, and Terenghi (1999, 688 citations) for neurotrophic delivery principles.

Recent Advances

Study Grinsell and Keating (2014, 1001 citations) for clinical therapies, Jessen et al. (2015, 717 citations) for Schwann roles, and Ghasemi-Mobarakeh et al. (2011, 692 citations) for scaffold applications.

Core Methods

Core techniques: exogenous GDNF injection (Terenghi, 1999), scaffold integration with conductive polymers (Ghasemi-Mobarakeh et al., 2011), receptor expression profiling in DRG (Bennett et al., 1998), and electrical stimulation for axon guidance.

How PapersFlow Helps You Research GDNF-Mediated Axon Regeneration

Discover & Search

PapersFlow's Research Agent uses searchPapers and exaSearch to find GDNF-specific papers like 'A Distinct Subgroup of Small DRG Cells Express GDNF Receptor Components' (Bennett et al., 1998), then citationGraph reveals connections to Terenghi (1999) on neurotrophic factors, while findSimilarPapers uncovers related Schwann cell works.

Analyze & Verify

Analysis Agent applies readPaperContent to extract GDNF signaling from Bennett et al. (1998), verifies claims with CoVe chain-of-verification against Fu and Gordon (1997), and uses runPythonAnalysis for statistical meta-analysis of regeneration rates across 10+ papers, graded via GRADE for evidence quality in axon outgrowth metrics.

Synthesize & Write

Synthesis Agent detects gaps in GDNF scaffold integration by flagging contradictions between Ghasemi-Mobarakeh et al. (2011) and Grinsell (2014), then Writing Agent uses latexEditText, latexSyncCitations for Bennett et al., and latexCompile to generate a review manuscript with exportMermaid diagrams of RET/NCAM cascades.

Use Cases

"Analyze GDNF dosage effects on DRG neuron survival from nerve injury papers using Python stats."

Research Agent → searchPapers('GDNF DRG nerve injury') → Analysis Agent → readPaperContent(Bennett 1998) → runPythonAnalysis(pandas meta-analysis of survival rates, matplotlib plots) → researcher gets CSV of effect sizes and p-values.

"Write LaTeX section on Schwann cell GDNF secretion for nerve repair review."

Synthesis Agent → gap detection(Terenghi 1999 + Jessen 2015) → Writing Agent → latexEditText('GDNF secretion mechanisms') → latexSyncCitations → latexCompile → researcher gets compiled PDF with cited figure of regeneration pathway.

"Find open-source code for GDNF scaffold simulation models from related papers."

Research Agent → paperExtractUrls(Ghasemi-Mobarakeh 2011) → Code Discovery → paperFindGithubRepo → githubRepoInspect → researcher gets annotated GitHub repos with scaffold conductivity simulations.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ GDNF papers via searchPapers → citationGraph → GRADE grading, producing structured report on RET signaling efficacy. DeepScan applies 7-step analysis with CoVe checkpoints to verify GDNF neuroprotection claims from Bennett et al. (1998). Theorizer generates hypotheses on GDNF-Schwann synergies from Terenghi (1999) and Jessen (2015).

Frequently Asked Questions

What is GDNF-mediated axon regeneration?

GDNF promotes peripheral axon regrowth via RET/NCAM signaling in small DRG neurons and Schwann cell secretion, enhancing growth cone responses post-injury (Bennett et al., 1998; Terenghi, 1999).

What are key methods for GDNF delivery?

Methods include exogenous administration, gene therapy, and scaffolds with electrical stimulation to mimic target reinnervation (Terenghi, 1999; Ghasemi-Mobarakeh et al., 2011).

What are the most cited papers?

Top papers are Fu and Gordon (1997, 1197 citations) on cellular basis, Bennett et al. (1998, 617 citations) on GDNF receptor subgroups, and Terenghi (1999, 688 citations) on neurotrophic factors.

What are open problems?

Challenges include incomplete recovery (<50% excellent function; Grinsell and Keating, 2014), targeting non-neurotrophin neurons, and clinical translation of GDNF scaffolds (Lindvall and Kokaia, 2010).

Research Nerve injury and regeneration with AI

PapersFlow provides specialized AI tools for Neuroscience researchers. Here are the most relevant for this topic:

See how researchers in Life Sciences use PapersFlow

Field-specific workflows, example queries, and use cases.

Life Sciences Guide

Start Researching GDNF-Mediated Axon Regeneration with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Neuroscience researchers